Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 1,800,000 | 1,500,000 | -300,000 | $64.04M | $65.82M | 6.93% | +$1.78M |
| Immunocore Holdings plcADS(IMCR) | 400,000 | 900,000 | +500,000 | $27.33M | $58.50M | 6.16% | +$31.17M |
| Immunovant, Inc.(IMVT) | 1,200,000 | 1,775,000 | +575,000 | $50.56M | $57.35M | 6.04% | +$6.79M |
| Ocular Therapeutix, Inc.(OCUL) | 4,000,000 | 5,811,436 | +1,811,436 | $17.84M | $51.99M | 5.47% | +$34.15M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 400,000 | +400,000 | $0 | $51.78M | 5.45% | +$51.78M |
| Olema Pharmaceuticals, Inc.(OLMA) | 4,383,875 | 4,383,875 | 0 | $54.38M | $49.63M | 5.22% | -$4.75M |
| Dyne Therapeutics, Inc.(DYN) | 1,880,000 | 1,730,000 | -150,000 | $25.00M | $49.11M | 5.17% | +$24.11M |
| Apellis Pharmaceuticals Inc COM | 950,000 | 800,000 | -150,000 | $56.87M | $47.02M | 4.95% | -$9.84M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,275,000 | 1,300,000 | +25,000 | $38.21M | $35.02M | 3.69% | -$3.19M |
| Silence Therapeutics plcADS(SLN) | 400,000 | 1,476,061 | +1,076,061 | $6.95M | $31.09M | 3.27% | +$24.14M |
| Structure Therapeutics IncADS | 1,070,058 | 720,058 | -350,000 | $43.62M | $30.86M | 3.25% | -$12.75M |
| Geron Corporation(GERN) | 0 | 9,000,000 | +9,000,000 | $0 | $29.70M | 3.13% | +$29.70M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 650,000 | +650,000 | $0 | $27.28M | 2.87% | +$27.28M |
| Enliven Therapeutics Inc | 307,076 | 1,574,220 | +1,267,144 | $4.25M | $26.41M | 2.78% | +$22.16M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 575,000 | +575,000 | $0 | $24.79M | 2.61% | +$24.79M |
| Annexon, Inc.(ANNX) | 4,950,000 | 3,050,000 | -1,900,000 | $22.47M | $21.87M | 2.30% | -$604.5K |
| Adverum Biotechnologies Inc | 0 | 1,499,999 | +1,499,999 | $0 | $21.21M | 2.23% | +$21.21M |
| Design Therapeutics, Inc.(DSGN) | 5,032,501 | 5,032,501 | 0 | $13.34M | $20.28M | 2.13% | +$6.94M |
| Akero Therapeutics Inc | 800,000 | 800,000 | 0 | $18.68M | $20.21M | 2.13% | +$1.53M |
| Astria Therapeutics Inc | 544,960 | 1,244,960 | +700,000 | $4.19M | $17.52M | 1.84% | +$13.34M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 40,000,000 | +40,000,000 | $0 | $16.54M | 1.74% | +$16.54M |
| Xencor, Inc.(XNCR) | 0 | 650,000 | +650,000 | $0 | $14.38M | 1.51% | +$14.38M |
| CG Oncology, Inc.(CGON) | 0 | 300,000 | +300,000 | $0 | $13.17M | 1.39% | +$13.17M |
| Engene Holdings Inc COM | 0 | 800,000 | +800,000 | $0 | $12.88M | 1.36% | +$12.88M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 500,000 | +500,000 | $0 | $12.42M | 1.31% | +$12.42M |
| Viridian Therapeutics, Inc.(VRDN) | 600,000 | 700,000 | +100,000 | $13.07M | $12.26M | 1.29% | -$811.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 700,000 | +700,000 | $0 | $11.93M | 1.26% | +$11.93M |
| Immatics N.V.SHS(IMTX) | 0 | 1,000,000 | +1,000,000 | $0 | $10.51M | 1.11% | +$10.51M |
| Spyre Therapeutics, Inc.(SYRE) | 150,000 | 250,000 | +100,000 | $3.23M | $9.48M | 1.00% | +$6.25M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 0 | 6,250,000 | +6,250,000 | $0 | $9.25M | 0.97% | +$9.25M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 150,000 | +150,000 | $0 | $9.15M | 0.96% | +$9.15M |
| Applied Therapeutics Inc | 1,660,000 | 1,350,000 | -310,000 | $5.56M | $8.98M | 0.94% | +$3.42M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 350,000 | +350,000 | $0 | $8.33M | 0.88% | +$8.33M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 2,200,000 | +2,200,000 | $0 | $7.59M | 0.80% | +$7.59M |
| Cytokinetics, Incorporated(CYTK) | 1,625,000 | 100,000 | -1,525,000 | $135.67M | $7.01M | 0.74% | -$128.66M |
| Kura Oncology, Inc.(KURA) | 0 | 300,000 | +300,000 | $0 | $6.40M | 0.67% | +$6.40M |
| Neumora Therapeutics, Inc.(NMRA) | 382,345 | 382,345 | 0 | $6.52M | $6.19M | 0.65% | -$325.9K |
| Atyr Pharma Inc | 5,850,000 | 3,100,000 | -2,750,000 | $8.25M | $6.04M | 0.64% | -$2.20M |
| Janux Therapeutics, Inc.(JANX) | 0 | 150,000 | +150,000 | $0 | $5.65M | 0.59% | +$5.65M |
| Elevation Oncology Inc | 0 | 1,000,000 | +1,000,000 | $0 | $5.13M | 0.54% | +$5.13M |
| Nextcure Inc | 0 | 1,925,000 | +1,925,000 | $0 | $4.29M | 0.45% | +$4.29M |
| Allakos Inc | 2,900,000 | 2,900,000 | 0 | $7.92M | $3.65M | 0.38% | -$4.26M |
| Unicycive Therapeutics Inc | 0 | 3,469,927 | +3,469,927 | $0 | $3.01M | 0.32% | +$3.01M |
| Boundless Bio, Inc.(BOLD) | 0 | 200,000 | +200,000 | $0 | $2.85M | 0.30% | +$2.85M |
| Tourmaline Bio Inc | 284,372 | 99,208 | -185,164 | $7.44M | $2.27M | 0.24% | -$5.17M |
| COMPASS Pathways plcADS(CMPS) | 500,000 | 257,980 | -242,020 | $4.38M | $1.81M | 0.19% | -$2.56M |
| Io Biotech Inc | 493,827 | 493,827 | 0 | $928.4K | $854.3K | 0.09% | -$74.1K |
| Immunic, Inc.(IMUX) | 421,184 | 421,184 | 0 | $631.8K | $556.0K | 0.06% | -$75.8K |
| Cypherpunk Technologies Inc.(CYPH) | 0 | 39,500 | +39,500 | $0 | $105.1K | 0.01% | +$105.1K |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 66,666 | 66,666 | 0 | $4.0K | $22.7K | 0.00% | +$18.7K |
| Acelyrin Inc | 1,250,000 | 0 | -1,250,000 | $9.32M | $0 | — | -$9.32M |
| Ambrx Biopharma Inc | 2,100,000 | 0 | -2,100,000 | $29.90M | $0 | — | -$29.90M |
| Arcus Biosciences, Inc.(RCUS) | 325,000 | 0 | -325,000 | $6.21M | $0 | — | -$6.21M |
| argenx SEADR(ARGX) | 145,000 | 0 | -145,000 | $55.16M | $0 | — | -$55.16M |
| Avidity Biosciences Inc | 775,000 | 0 | -775,000 | $7.01M | $0 | — | -$7.01M |
| Delcath Systems, Inc.(DCTH) | 300,000 | 0 | -300,000 | $1.25M | $0 | — | -$1.25M |
| Edgewise Therapeutics, Inc.(EWTX) | 950,000 | 0 | -950,000 | $10.39M | $0 | — | -$10.39M |
| Fulcrum Therapeutics, Inc.(FULC) | 1,200,000 | 0 | -1,200,000 | $8.10M | $0 | — | -$8.10M |
| Icosavax Inc | 300,000 | 0 | -300,000 | $4.73M | $0 | — | -$4.73M |
| Inhibrx Inc | 100,000 | 0 | -100,000 | $3.80M | $0 | — | -$3.80M |
| Karuna Therapeutics Inc | 90,000 | 0 | -90,000 | $28.49M | $0 | — | -$28.49M |
| Kiniksa Pharmaceuticals LtdCL A | 150,000 | 0 | -150,000 | $2.63M | $0 | — | -$2.63M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 150,000 | 0 | -150,000 | $9.06M | $0 | — | -$9.06M |
| Morphic Hldg Inc | 200,000 | 0 | -200,000 | $5.78M | $0 | — | -$5.78M |
| Morphosys AgADS | 1,475,000 | 0 | -1,475,000 | $14.60M | $0 | — | -$14.60M |
| Rayzebio Inc | 568,173 | 0 | -568,173 | $35.32M | $0 | — | -$35.32M |
| Repare Therapeutics Inc | 600,000 | 0 | -600,000 | $4.38M | $0 | — | -$4.38M |
| Revolution Medicines, Inc.(RVMD) | 350,000 | 0 | -350,000 | $10.04M | $0 | — | -$10.04M |
| Ventyx Biosciences Inc | 2,000,000 | 0 | -2,000,000 | $4.94M | $0 | — | -$4.94M |
| Xenon Pharmaceuticals Inc.(XENE) | 150,000 | 0 | -150,000 | $6.91M | $0 | — | -$6.91M |